Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	24.86	19.71	15.79
Graham Fair Price	308.77	5.57	1.36
PEG	-99.64	< 0.005	1.01
Price/Book	-15.01	0.25	0.30
Price/Cash Flow	90.13	-3.28	-33.18
Prices/Earnings	-94.23	6.10	-105.74
Price/Sales	25.63	1.38	1.10
Price/FCF	90.13	-3.28	-33.18
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.96	0.08	0.08
Operating Margin	141.02	0.04	-0.02
ROA	1431.57	< 0.005	< 0.005
ROE	< 0.005	0.01	1373.34
ROIC	< 0.005	< 0.005	35.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	0.09	44.12
Dividends QOQ	-0.67	-0.10	85.61
EBIT QOQ	-1.39	2.65	90.06
EPS QOQ	-1.05	16.79	1497.98
FCF QOQ	-2.18	-7.71	-253.64
Revenue QOQ	-0.13	-0.32	-141.36
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	51.94	79.34	52.75
Days Sales Outstanding (DSO)	32.90	31.14	-5.36
Inventory Turnover	1.73	1.13	-34.54
Debt/Capitalization	0.20	0.22	8.74
Quick Ratio	0.82	0.72	-11.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.81	11.51	6.50
Cash	4.83	4.15	-14.10
Capex	-0.35	-0.29	17.10
Free Cash Flow	-0.10	-0.89	-816.94
Revenue	2.94	2.12	-27.96
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.31	1.34	2.33
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-21.01	-5.80	72.39
Naive Interpretation	Member

06 - Financial Health · Weak

Rating